DrugPatentWatch Database Preview
Drugs in Development Information for fluoruracil
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for fluoruracil?
fluoruracil is an investigational drug.
There have been 26 clinical trials for fluoruracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2007.
The most common disease conditions in clinical trials are Breast Neoplasms, Stomach Neoplasms, and Colorectal Neoplasms. The leading clinical trial sponsors are Hellenic Oncology Research Group, University Hospital of Crete, and AHS Cancer Control Alberta.
Summary for fluoruracil
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2007-06-01) |
| Vendors | 0 |
Recent Clinical Trials for fluoruracil
| Title | Sponsor | Phase |
|---|---|---|
| Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients | Gruppo Oncologico Italiano di Ricerca Clinica | Phase 2 |
| First-line Therapy in Metastatic PDAC | Ludwig-Maximilians - University of Munich | Phase 2 |
| Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer | Chungnam National University Hospital | Phase 2 |
Clinical Trial Summary for fluoruracil
Top disease conditions for fluoruracil
Top clinical trial sponsors for fluoruracil
US Patents for fluoruracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
